BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1999226)

  • 21. [Influence of the peroxisome proliferator-activated receptor alpha on the development of T and B cells in mice].
    Yang J; Li A; Yang Q; Li X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):296-8. PubMed ID: 16643783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of cell survival during B lymphopoiesis: increased pre-B cell apoptosis in CD24-transgenic mouse bone marrow.
    Lu L; Chappel MS; Humphries RK; Osmond DG
    Eur J Immunol; 2000 Sep; 30(9):2686-91. PubMed ID: 11009103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriate developmental expression of human CD8 beta in transgenic mice.
    Kieffer LJ; Yan L; Hanke JH; Kavathas PB
    J Immunol; 1997 Nov; 159(10):4907-12. PubMed ID: 9366416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [IL-7].
    Yasunaga M; Nishikawa S
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2077-83. PubMed ID: 8085864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perturbed development of T and B cells in mice expressing an Hlx homeobox transgene.
    Allen JD; Harris AW; Bath ML; Strasser A; Scollay R; Adams JM
    J Immunol; 1995 Feb; 154(4):1531-42. PubMed ID: 7836739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic expression of VpreB-3 under the control of the immunoglobulin heavy chain enhancer and SV40 promoter.
    Hagiwara S
    Kobe J Med Sci; 1996 Feb; 42(1):43-59. PubMed ID: 8984229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mouse carrying genetic defect in the choice between T and B lymphocytes.
    Tokoro Y; Sugawara T; Yaginuma H; Nakauchi H; Terhorst C; Wang B; Takahama Y
    J Immunol; 1998 Nov; 161(9):4591-8. PubMed ID: 9794386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expansion of myelopoietic precursors and inhibition of B-cell precursors in mice that express a T-cell receptor gamma (V gamma 1.1J gamma 4C gamma 4) transgene.
    Ferrick DA; Cumano A; Furlonger C; Min X; Iscove NN; Paige CJ; Mak TW
    J Cell Physiol; 1991 Sep; 148(3):457-63. PubMed ID: 1833413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological and clinical implications of interleukin-7 and lymphopoiesis.
    Appasamy PM
    Cytokines Cell Mol Ther; 1999 Mar; 5(1):25-39. PubMed ID: 10390077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow-derived cells are responsible for the development of autoimmune arthritis in human T cell leukemia virus type I-transgenic mice and those of normal mice can suppress the disease.
    Saijo S; Kotani M; Habu K; Ishitsuka C; Yamamoto H; Sekiguchi T; Iwakura Y
    J Immunol; 1999 Nov; 163(10):5700-7. PubMed ID: 10553101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early B cell precursors in long-term bone marrow culture: selective development in the bone marrow of irradiated recipients.
    Nishikawa S; Kina T; Amagai T; Katsura Y
    Eur J Immunol; 1985 Jul; 15(7):696-701. PubMed ID: 3159587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional maturation of murine B lymphocyte precursors. II. Analysis of cells required from the bone marrow microenvironment.
    Gisler RH; Söderberg A; Kamber M
    J Immunol; 1987 Apr; 138(8):2433-8. PubMed ID: 3494066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-7, a major T-lymphocyte cytokine.
    Costello R; Imbert J; Olive D
    Eur Cytokine Netw; 1993; 4(4):253-62. PubMed ID: 8268415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The distribution of CD10 (NEP 24.11, CALLA) in humans and mice is similar in non-lymphoid organs but differs within the hematopoietic system: absence on murine T and B lymphoid progenitors.
    Kalled SL; Siva N; Stein H; Reinherz EL
    Eur J Immunol; 1995 Mar; 25(3):677-87. PubMed ID: 7705396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maturation of B cell precursors is impaired in thymic-deprived nude and old mice.
    Szabo P; Zhao K; Kirman I; Le Maoult J; Dyall R; Cruikshank W; Weksler ME
    J Immunol; 1998 Sep; 161(5):2248-53. PubMed ID: 9725218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoproliferative disorders in an IL-7 transgenic mouse line.
    Fisher AG; Burdet C; LeMeur M; Haasner D; Gerber P; Ceredig R
    Leukemia; 1993 Aug; 7 Suppl 2():S66-8. PubMed ID: 8361236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autocrine expression of interleukin-7 rescues lymphoid expansion in interleukin-7-deficient mice.
    Rich BE
    Immunology; 1997 Nov; 92(3):374-80. PubMed ID: 9486111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic expression of interleukin 7 restores T cell populations in nude mice.
    Rich BE; Leder P
    J Exp Med; 1995 Mar; 181(3):1223-8. PubMed ID: 7869039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential.
    Fisher AG; Burdet C; Bunce C; Merkenschlager M; Ceredig R
    Int Immunol; 1995 Mar; 7(3):415-23. PubMed ID: 7794821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.
    von Freeden-Jeffry U; Vieira P; Lucian LA; McNeil T; Burdach SE; Murray R
    J Exp Med; 1995 Apr; 181(4):1519-26. PubMed ID: 7699333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.